INVA · Innoviva Inc
United States · RS rating 62 · As of 2026-11-03
| Price | 20.93 USD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 62 / 62 / 71 / 64 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 33 / 28 / 52 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +79.6% |
| Sales growth Q/Q | +6.3% |
| Distance from 52-week high | +13.7% |
| Market cap (USD) | $1.7B |